FDA Drug Application (062703) for CEPHALEXIN by TEVA

Back to FDA Applications sponsored by TEVA

Application Number062703
Product Number001
FormFOR SUSPENSION;ORAL
DosageEQ 125MG BASE/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCEPHALEXIN
Active IngredientCEPHALEXIN

Active IngredientCount
List of drugs with Active Ingredient CEPHALEXIN4


Back to FDA Applications sponsored by TEVA